What is Callan JMB Inc. Common Stock?
, through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry.
CJMB · Verdict
Limited reward · moderate risk
CJMB stands out on volatility and balance sheet, but watch the growth signal.
Based on 88% data coverage
CJMB · Verdict
Top decile vs peers
Current ratio 2.59
8% free-cash-flow margin
Revenue -46.3% CAGR
-35% net margin · -155% ROE
Model-based scoring. For information only — not financial advice.
, through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company is listed on the NASDAQ in USA, operating in the Industrials sector, with a market capitalisation of 6.59M.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.